Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture

Metabolism - Tập 57 - Trang S58-S64 - 2008
Zhong Q. Wang1, David Ribnicky2, Xian H. Zhang1, Ilya Raskin2, Yongmei Yu1, William T. Cefalu1
1Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
2Biotech Center, Rutgers University, New Brunswick, NJ 08901, USA

Tài liệu tham khảo

DeFronzo, 1992, Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web, J Cardiovasc Pharmacol, 20, S1, 10.1097/00005344-199200111-00002 Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595 Haffner, 1996, The insulin resistance syndrome revisited, Diabetes Care, 19, 275, 10.2337/diacare.19.3.275 American Diabetes Association, 2007, Nutrition recommendations and interventions for diabetes, Diabetes Care, 30, S48, 10.2337/dc07-S048 Nissen, 2007, Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes, N Engl J Med, 356, 2457, 10.1056/NEJMoa072761 Gibson, 2005, Can claims, misleading information and manufacturing issues regulating dietary supplements be improved in the United States of America?, J Pharmacol Exp Ther, 314, 939, 10.1124/jpet.105.085712 Neuhouser, 2003, Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs, J Nutr, 133, 1992S, 10.1093/jn/133.6.1992S Witters, 2001, The blooming of the French lilac, J Clin Invest, 108, 1105, 10.1172/JCI14178 Swanston-Flatt, 1991, Traditional dietary adjuncts for the treatment of diabetes mellitus, Proc Nutr Soc, 50, 641, 10.1079/PNS19910077 Ribnicky, 2006, Antihyperglycemic activity of TARRALIN, an ethanolic extract of Artemisia dracunculus L, Phytomedicine, 13, 550, 10.1016/j.phymed.2005.09.007 Henry, 1995, Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels, Diabetes, 45, 400, 10.2337/diabetes.45.4.400 Gomez-Lechon, 1996, A microassay for measuring glycogen in 96-well cultured cells, Analytical Biochemistry, 236, 296, 10.1006/abio.1996.0170 Cefalu, 2002, Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats, J Nutr, 132, 1107, 10.1093/jn/132.6.1107 Wang, 1997, Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats, Exp Gerontol, 32, 671, 10.1016/S0531-5565(97)00054-5 Goodyear, 1995, Insulin receptor phosphorylation, insulin receptor substrate–1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects, J Clin Invest., 95, 2195, 10.1172/JCI117909 Wang, 2006, Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats, J Nutr., 136, 415, 10.1093/jn/136.2.415 Macaulay, 2005, Constitutive activation of GSK3 down regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells, J Biol Chem, 280, 9509, 10.1074/jbc.M411648200 Cha, 2005, Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists, Am J Physiol Endocrinol Metab, 289, E151, 10.1152/ajpendo.00141.2004 Ciaraldi, 1995, Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non–insulin-dependent diabetes mellitus subjects, J Clin Invest, 96, 2820, 10.1172/JCI118352 Henry, 1995, Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures, Diabetes, 44, 936, 10.2337/diabetes.44.8.936 Ukropcova, 2005, Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor, J Clin Invest, 115, 1934, 10.1172/JCI24332 Hanson, 1997, Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression, Annu Rev Biochem, 66, 581, 10.1146/annurev.biochem.66.1.581 Dube, 2005, Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer, Biochim Biophys Acta, 1754, 108, 10.1016/j.bbapap.2005.07.030 Goldstein, 2001, Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance, Curr Drug Targets Immune Endocr Metabol Disord, 1, 265, 10.2174/1568008013341163 Tonks, 2001, Combinatorial control of the specificity of protein tyrosine phosphatases, Curr Opin Cell Biol, 13, 182, 10.1016/S0955-0674(00)00196-4 Zhang, 2001, Protein tyrosine phosphatases: prospects for therapeutics, Curr Opin Chem Biol, 5, 416, 10.1016/S1367-5931(00)00223-4 Ahmad, 1997, Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes, J Clin Invest, 100, 449, 10.1172/JCI119552 Goldstein, 2002, Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance, J Clin Endocrinol Metab, 87, 2474, 10.1210/jc.87.6.2474 Santaniemi, 2004, Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes, J Intern Med, 256, 48, 10.1111/j.1365-2796.2004.01339.x Seely, 1996, Protein tyrosine phosphatase 1B interacts with the activated insulin receptor, Diabetes, 45, 1379, 10.2337/diabetes.45.10.1379 Bandyopadhyay, 1997, Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin, J Biol Chem, 272, 1639, 10.1074/jbc.272.3.1639 Wang, 2001, Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors, Mol Cell Endocrinol, 173, 109, 10.1016/S0303-7207(00)00402-0 Puius, 1997, Identification of a second aryl phosphate–binding site in protein-tyrosine phosphatase 1b—a paradigm for inhibitor design, Proc Natl Acad Sci, 94, 13420, 10.1073/pnas.94.25.13420 Salmeen, 2000, Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B, Mol Cell, 6, 1401, 10.1016/S1097-2765(00)00137-4 Calera, 2000, Dynamics of protein-tyrosine phosphatases in rat adipocytes, J Biol Chem, 275, 6308, 10.1074/jbc.275.9.6308